taxonomy (2)
protein (51)
source (4)
structure (13)
composition (1)
disease (3)
reference (8)
site (79)
peptide (83)
- 4F2 cell-surface antigen heavy chain / Homo sapiens P08195
- Acid ceramidase / Homo sapiens Q13510
- Alpha-galactosidase A / Homo sapiens P06280
- Alpha-n-acetylgalactosaminidase / Homo sapiens P17050
- Alpha-n-acetylglucosaminidase / Homo sapiens P54802
- Azurocidin / Homo sapiens P20160
- Biglycan / Homo sapiens P21810
- Carboxypeptidase D / Homo sapiens O75976
- Cathepsin D / Homo sapiens P07339
- CD166 antigen / Homo sapiens Q13740
- CD276 antigen / Homo sapiens Q5ZPR3
- Clusterin / Homo sapiens P10909
- Collagen alpha-1(XII) chain / Homo sapiens Q99715
- Collagen alpha-1(XIV) chain / Homo sapiens Q05707
- Complement decay-accelerating factor / Homo sapiens P08174
- Decorin / Homo sapiens P07585
- Disintegrin and metalloproteinase domain-containing protein 15 / Homo sapiens Q13444
- Ectonucleoside triphosphate diphosphohydrolase 2 / Homo sapiens Q9Y5L3
- Fibrillin-1 / Homo sapiens P35555
- Fibronectin / Homo sapiens P02751
- Galectin-3-binding protein / Homo sapiens Q08380
- Gamma-glutamyl hydrolase / Homo sapiens Q92820
- Glucosylceramidase / Homo sapiens P04062
- Golgi apparatus protein 1 / Homo sapiens Q92896
- Golgi membrane protein 1 / Homo sapiens Q8NBJ4
- Immunoglobulin superfamily member 8 / Homo sapiens Q969P0
- Integrin alpha-6 / Homo sapiens P23229
- Integrin alpha-V / Homo sapiens P06756
- Integrin beta-1 / Homo sapiens P05556
- Lactotransferrin / Homo sapiens P02788
- Lysosomal acid phosphatase / Homo sapiens P11117
- Lysosomal alpha-mannosidase / Homo sapiens O00754
- Lysosome membrane protein 2 / Homo sapiens Q14108
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens P11279
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens P13473
- Myelin protein zero-like protein 1 / Homo sapiens O95297
- Myelin protein zero-like protein 2 / Homo sapiens O60487
- Periostin / Homo sapiens Q15063
- Plexin-B2 / Homo sapiens O15031
- Polymeric immunoglobulin receptor / Homo sapiens P01833
- Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens Q07954
- Prosaposin / Homo sapiens P07602
- Prostaglandin F2 receptor negative regulator / Homo sapiens Q9P2B2
- Sparc / Homo sapiens P09486
- Tetraspanin-3 / Homo sapiens O60637
- Thrombospondin-1 / Homo sapiens P07996
- Transmembrane 9 superfamily member 3 / Homo sapiens Q9HD45
- Transmembrane glycoprotein NMB / Homo sapiens Q14956
- Vitronectin / Homo sapiens P04004
- Zinc-alpha-2-glycoprotein / Homo sapiens P25311
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- Mammary Gland (UBERON_0001911)
- Milk (UBERON_0001913)
- Urine (UBERON_0001088)
- BTI-Tn-5B1-4 (CVCL_C190)
Source
- Free / Lactose / [[Fuc(a1-2)]Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)][Gal(b1-3)GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / [[Fuc(a1-2)]Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)][Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / [[Fuc(a1-2)]Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)][[Fuc(a1-2)]Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / [[Fuc(a1-2)]Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)][Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / [Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)][Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / [Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)][Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / [Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)][Gal(b1-3)GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / [Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)][Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / [Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)][[Fuc(a1-2)]Gal(b1-3)GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / [Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)][Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / [Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)][Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / No-core / Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-3)[Fuc(a1-3)[Gal(b1-4)]GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc
- N-Linked / Hybrid / Structure 3266
Reported structure
- Hex:5 HexNAc:3 dHex:2 (avg mass : 1730.5983 )
Composition
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
- Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: Implications for vaccination and antibody therapeutics (2020 - Dapeng Zhou, Xiaoxu Tian, Ruibing Qi, Chao Peng, Wen Zhang) / Status : Reviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Creating a Mass Spectral Reference Library for Oligosaccharides in Human Milk (2018 - Connie A Remoroza, Tytus D Mak, Maria Lorna A De Leoz, Yuri A Mirokhin, Stephen E Stein) / Status : Unreviewed
- Synthesis of Asymmetrical Multiantennary Human Milk Oligosaccharides (2017 - Anthony R Prudden, Lin Liu, Chantelle J Capicciotti, Margreet A Wolfert, Shuo Wang, Zhongwei Gao, Lu Meng, Kelley W Moremen, Geert-Jan Boons) / Status : Unreviewed
- Automated assignments of N- and O-site specific glycosylation with extensive glycan heterogeneity of glycoprotein mixtures (2013 - Strum JS1, Nwosu CC, Hua S, Kronewitter SR, Seipert RR, Bachelor RJ, An HJ, Lebrilla CB) / Status : Reviewed
- Development of an Annotated Library of Neutral Human Milk Oligosaccharides (2010 - Shuai Wu, Nannan Tao, J Bruce German, Rudolf Grimm, Carlito B Lebrilla) / Status : Unreviewed
- Urinary oligosaccharides of fucosidosis. Evidence of the occurrence of X-antigenic determinant in serum-type sugar chains of glycoproteins. (1978 - Nishigaki M, Yamashita K, Matsuda I, Arashima S, Kobata A) / Status : Reviewed
Reference
- 4F2 cell-surface antigen heavy chain / Homo sapiens
- Acid ceramidase / Homo sapiens
- Alpha-galactosidase A / Homo sapiens
- Alpha-n-acetylgalactosaminidase / Homo sapiens
- Alpha-n-acetylglucosaminidase / Homo sapiens
- Azurocidin / Homo sapiens
- Biglycan / Homo sapiens
- Carboxypeptidase D / Homo sapiens
- Cathepsin D / Homo sapiens
- CD166 antigen / Homo sapiens
- CD276 antigen / Homo sapiens
- Clusterin / Homo sapiens
- Collagen alpha-1(XII) chain / Homo sapiens
- Collagen alpha-1(XIV) chain / Homo sapiens
- Complement decay-accelerating factor / Homo sapiens
- Decorin / Homo sapiens
- Disintegrin and metalloproteinase domain-containing protein 15 / Homo sapiens
- Ectonucleoside triphosphate diphosphohydrolase 2 / Homo sapiens
- Fibrillin-1 / Homo sapiens
- Fibronectin / Homo sapiens
- Galectin-3-binding protein / Homo sapiens
- Gamma-glutamyl hydrolase / Homo sapiens
- Glucosylceramidase / Homo sapiens
- Golgi apparatus protein 1 / Homo sapiens
- Golgi membrane protein 1 / Homo sapiens
- Immunoglobulin superfamily member 8 / Homo sapiens
- Integrin alpha-6 / Homo sapiens
- Integrin alpha-V / Homo sapiens
- Integrin beta-1 / Homo sapiens
- Lactotransferrin / Homo sapiens
- Lysosomal acid phosphatase / Homo sapiens
- Lysosomal alpha-mannosidase / Homo sapiens
- Lysosome membrane protein 2 / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Myelin protein zero-like protein 1 / Homo sapiens
- Myelin protein zero-like protein 2 / Homo sapiens
- Periostin / Homo sapiens
- Plexin-B2 / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens
- Prosaposin / Homo sapiens
- Prostaglandin F2 receptor negative regulator / Homo sapiens
- Sparc / Homo sapiens
- Tetraspanin-3 / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Transmembrane 9 superfamily member 3 / Homo sapiens
- Transmembrane glycoprotein NMB / Homo sapiens
- Vitronectin / Homo sapiens
- Zinc-alpha-2-glycoprotein / Homo sapiens
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- VIEAVNGTDAR (11aa)
- WQMNFTVR (8aa)
- EIFVANGTQGK (11aa)
- YETTNK (6aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- AIGFENATQAIGR (13aa)
- ANTTQPGIVEGGQVIK (16aa)
- ENTSDPSIVIAFGR (14aa)
- SSCGKENTSDPSIVIAFGR (19aa)
- GSQWSDIEEFCNR (13aa)
- TCDWIPKPNMSASCK (15aa)
- LPGVCNETMMALWEECKPCLK (21aa)
- TAIFPDIIAQGNASIR (16aa)
- ANIQFGDNGTTISAVSNK (18aa)
- VCSNDNK (7aa)
- AASTYSIDSVSFSYNTGDNTTFPDAEDK (28aa)
- SIDSVSFSYNTGDNTTFPDAEDK (23aa)
- FGCEIENNR (9aa)
- DASINIENMQFIHNGTYICDVK (22aa)
- KDASINIENMQFIHNGTYICDVK (23aa)
- FNPNISWQPIPVHTVPITEDR (21aa)
- GLSFDVSLEVSQGPGLLNDTK (21aa)
- VKVVDRGNGSRPSSPEEVK (19aa)
- IGIYADVGNK (10aa)
- NQTNIER (7aa)
- LNLTTDPK (8aa)
- VYSSANNCTFE (11aa)
- NQSVPISCCR (10aa)
- NGSLFAFR (8aa)
- FVNVTVTPEDQCRPNNVCTGVITR (24aa)
- IVDVNITSEGK (11aa)
- MAAAINATGR (10aa)
- TYTYADTPDDFQIHNFSIPEEDTK (24aa)
- VSVNTANVTIGPQIMEVTVYR (21aa)
- NFTMNEK (7aa)
- IADTNITSIPQGIPPSITEIHIDGNK (26aa)
- LRNPCTSEQNCTSPFSYK (18aa)
- DFQHIINR (8aa)
- KDNTTVTR (8aa)
- TVIENSTSYEEAK (13aa)
- FPQVNVTK (8aa)
- IININPNK (8aa)
- GSISYINVTR (10aa)
- LNSSTIK (7aa)
- GFSTQVLLGDVYQSPCTMAQRPQNFNSSAR (30aa)
- ELDLTCNITTDR (12aa)
- IIQVVYIHSNNITK (14aa)
- IGPGEPIEIICNVSGAIPPAGR (22aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- FPNITNLCPFGEVFNATR (18aa)
- LIDNNK (6aa)
- VQPFNVTQGK (10aa)
- VSCPIMPCSNATVPDGECCPR (21aa)
- DASSFIAEWQNITK (14aa)
- IANITQGEDQYYIR (14aa)
- IIISPEENVTITCTAENQIER (21aa)
- WNNTGCQALPSQDEGPSK (18aa)
- KENSSEICSNNGECVCGQCVCR (22aa)
- SCVAVTSAQPQNMSR (15aa)
- RHEEGHMINCTCFGQGR (17aa)
- EVNDTLLVNELK (12aa)
- NNSNNFDLNR (10aa)
- AGCLIGAEHVNNSYE (15aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- INQTEPVAGNYYPVNTR (17aa)
- QLSCVANQNGSQADCELGNPFK (22aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- VVNSTTGPGEHIR (13aa)
- CDSGFALDSEERNCTDIDECR (21aa)
- KNFTTAPAICHDGK (14aa)
- VPAQEKNFTTAPAICHDGK (19aa)
- GVFVSNGTHWFVTQR (15aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- VAKNLNESLIDLQE (14aa)
- DNTTCYEFK (9aa)
- NLQVYNATSNSLTVK (15aa)
- MIEAYNITEK (10aa)
- EAGNITTDGYEIIGK (15aa)
- LNGTDPIVAADSK (13aa)
Mass spectrometry observed peptide
-
- Free / Lactose (avg mass : 1730.5983)
- Milk (UBERON_0001913)
-
- Free / Lactose (avg mass : 1730.5983)
- Milk (UBERON_0001913)
-
- Free / Lactose (avg mass : 1730.5983)
- Milk (UBERON_0001913)
-
- Free / Lactose (avg mass : 1730.5983)
- Milk (UBERON_0001913)
-
- Free / Lactose (avg mass : 1730.5983)
- Milk (UBERON_0001913)
- Creating a Mass Spectral Reference Library for Oligosaccharides in Human Milk (2018 - Connie A Remoroza, Tytus D Mak, Maria Lorna A De Leoz, Yuri A Mirokhin, Stephen E Stein) / Status : Unreviewed
- Development of an Annotated Library of Neutral Human Milk Oligosaccharides (2010 - Shuai Wu, Nannan Tao, J Bruce German, Rudolf Grimm, Carlito B Lebrilla) / Status : Unreviewed
-
- Free / Lactose (avg mass : 1730.5983)
- Milk (UBERON_0001913)
- Creating a Mass Spectral Reference Library for Oligosaccharides in Human Milk (2018 - Connie A Remoroza, Tytus D Mak, Maria Lorna A De Leoz, Yuri A Mirokhin, Stephen E Stein) / Status : Unreviewed
- Development of an Annotated Library of Neutral Human Milk Oligosaccharides (2010 - Shuai Wu, Nannan Tao, J Bruce German, Rudolf Grimm, Carlito B Lebrilla) / Status : Unreviewed
-
- Free / Lactose (avg mass : 1730.5983)
- Milk (UBERON_0001913)
- Creating a Mass Spectral Reference Library for Oligosaccharides in Human Milk (2018 - Connie A Remoroza, Tytus D Mak, Maria Lorna A De Leoz, Yuri A Mirokhin, Stephen E Stein) / Status : Unreviewed
- Development of an Annotated Library of Neutral Human Milk Oligosaccharides (2010 - Shuai Wu, Nannan Tao, J Bruce German, Rudolf Grimm, Carlito B Lebrilla) / Status : Unreviewed
-
- Free / Lactose (avg mass : 1730.5983)
- Milk (UBERON_0001913)
-
- Free / Lactose (avg mass : 1730.5983)
- Milk (UBERON_0001913)
-
- Free / Lactose (avg mass : 1730.5983)
- Milk (UBERON_0001913)
-
- Free / Lactose (avg mass : 1730.5983)
- Milk (UBERON_0001913)
-
- Free / No-core (avg mass : 1730.5983)
- Urine (UBERON_0001088)
- Fucosidosis (DOID:14500)
-
- N-Linked / Hybrid (avg mass : 1730.5983)
- Milk (UBERON_0001913)
- Lactotransferrin / Homo sapiens
-
- Hex:5 HexNAc:3 dHex:2 / N-Linked (avg mass : 1730.5983)
- N-Linked / Hybrid / Structure 3266
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
- Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: Implications for vaccination and antibody therapeutics (2020 - Dapeng Zhou, Xiaoxu Tian, Ruibing Qi, Chao Peng, Wen Zhang) / Status : Reviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- 4F2 cell-surface antigen heavy chain / Homo sapiens
- Acid ceramidase / Homo sapiens
- Alpha-galactosidase A / Homo sapiens
- Alpha-n-acetylgalactosaminidase / Homo sapiens
- Alpha-n-acetylglucosaminidase / Homo sapiens
- Azurocidin / Homo sapiens
- Biglycan / Homo sapiens
- Carboxypeptidase D / Homo sapiens
- Cathepsin D / Homo sapiens
- CD166 antigen / Homo sapiens
- CD276 antigen / Homo sapiens
- Clusterin / Homo sapiens
- Collagen alpha-1(XII) chain / Homo sapiens
- Collagen alpha-1(XIV) chain / Homo sapiens
- Complement decay-accelerating factor / Homo sapiens
- Decorin / Homo sapiens
- Disintegrin and metalloproteinase domain-containing protein 15 / Homo sapiens
- Ectonucleoside triphosphate diphosphohydrolase 2 / Homo sapiens
- Fibrillin-1 / Homo sapiens
- Fibronectin / Homo sapiens
- Galectin-3-binding protein / Homo sapiens
- Gamma-glutamyl hydrolase / Homo sapiens
- Glucosylceramidase / Homo sapiens
- Golgi apparatus protein 1 / Homo sapiens
- Golgi membrane protein 1 / Homo sapiens
- Immunoglobulin superfamily member 8 / Homo sapiens
- Integrin alpha-6 / Homo sapiens
- Integrin alpha-V / Homo sapiens
- Integrin beta-1 / Homo sapiens
- Lysosomal acid phosphatase / Homo sapiens
- Lysosomal alpha-mannosidase / Homo sapiens
- Lysosome membrane protein 2 / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Myelin protein zero-like protein 1 / Homo sapiens
- Myelin protein zero-like protein 2 / Homo sapiens
- Periostin / Homo sapiens
- Plexin-B2 / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens
- Prosaposin / Homo sapiens
- Prostaglandin F2 receptor negative regulator / Homo sapiens
- Sparc / Homo sapiens
- Tetraspanin-3 / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Transmembrane 9 superfamily member 3 / Homo sapiens
- Transmembrane glycoprotein NMB / Homo sapiens
- Vitronectin / Homo sapiens
- Zinc-alpha-2-glycoprotein / Homo sapiens
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- VIEAVNGTDAR (11aa)
- WQMNFTVR (8aa)
- EIFVANGTQGK (11aa)
- YETTNK (6aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- AIGFENATQAIGR (13aa)
- ANTTQPGIVEGGQVIK (16aa)
- ENTSDPSIVIAFGR (14aa)
- SSCGKENTSDPSIVIAFGR (19aa)
- GSQWSDIEEFCNR (13aa)
- TCDWIPKPNMSASCK (15aa)
- LPGVCNETMMALWEECKPCLK (21aa)
- TAIFPDIIAQGNASIR (16aa)
- ANIQFGDNGTTISAVSNK (18aa)
- VCSNDNK (7aa)
- AASTYSIDSVSFSYNTGDNTTFPDAEDK (28aa)
- SIDSVSFSYNTGDNTTFPDAEDK (23aa)
- FGCEIENNR (9aa)
- DASINIENMQFIHNGTYICDVK (22aa)
- KDASINIENMQFIHNGTYICDVK (23aa)
- FNPNISWQPIPVHTVPITEDR (21aa)
- GLSFDVSLEVSQGPGLLNDTK (21aa)
- VKVVDRGNGSRPSSPEEVK (19aa)
- IGIYADVGNK (10aa)
- NQTNIER (7aa)
- LNLTTDPK (8aa)
- VYSSANNCTFE (11aa)
- NQSVPISCCR (10aa)
- NGSLFAFR (8aa)
- FVNVTVTPEDQCRPNNVCTGVITR (24aa)
- IVDVNITSEGK (11aa)
- MAAAINATGR (10aa)
- TYTYADTPDDFQIHNFSIPEEDTK (24aa)
- VSVNTANVTIGPQIMEVTVYR (21aa)
- NFTMNEK (7aa)
- IADTNITSIPQGIPPSITEIHIDGNK (26aa)
- LRNPCTSEQNCTSPFSYK (18aa)
- DFQHIINR (8aa)
- KDNTTVTR (8aa)
- TVIENSTSYEEAK (13aa)
- FPQVNVTK (8aa)
- IININPNK (8aa)
- GSISYINVTR (10aa)
- LNSSTIK (7aa)
- GFSTQVLLGDVYQSPCTMAQRPQNFNSSAR (30aa)
- ELDLTCNITTDR (12aa)
- IIQVVYIHSNNITK (14aa)
- IGPGEPIEIICNVSGAIPPAGR (22aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- FPNITNLCPFGEVFNATR (18aa)
- LIDNNK (6aa)
- VQPFNVTQGK (10aa)
- VSCPIMPCSNATVPDGECCPR (21aa)
- DASSFIAEWQNITK (14aa)
- IANITQGEDQYYIR (14aa)
- IIISPEENVTITCTAENQIER (21aa)
- WNNTGCQALPSQDEGPSK (18aa)
- KENSSEICSNNGECVCGQCVCR (22aa)
- SCVAVTSAQPQNMSR (15aa)
- RHEEGHMINCTCFGQGR (17aa)
- EVNDTLLVNELK (12aa)
- NNSNNFDLNR (10aa)
- AGCLIGAEHVNNSYE (15aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- INQTEPVAGNYYPVNTR (17aa)
- QLSCVANQNGSQADCELGNPFK (22aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- VVNSTTGPGEHIR (13aa)
- CDSGFALDSEERNCTDIDECR (21aa)
- KNFTTAPAICHDGK (14aa)
- VPAQEKNFTTAPAICHDGK (19aa)
- GVFVSNGTHWFVTQR (15aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- VAKNLNESLIDLQE (14aa)
- DNTTCYEFK (9aa)
- NLQVYNATSNSLTVK (15aa)
- MIEAYNITEK (10aa)
- EAGNITTDGYEIIGK (15aa)
- LNGTDPIVAADSK (13aa)
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reference
Reported glycosite
Source
Disease
Reference
Reported glycosite
Source
Disease
Reference
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
